Meeting
2015 Gastrointestinal Cancers Symposium
Awareness of KRAS testing by oncologists and panitumumab use in colorectal cancer patients: A European survey.
Authors
Jorg Trojan
Johann Wolfgang Goethe University, Frankfurt, Germany
Jorg Trojan , Aliki Taylor , Jan-Henrik Terwey , Gerry Downey , George Kafatos , Pilar Garcia Alfonso , Jiri Tomasek , Laurent Mineur , Han van Krieken , Giuseppe Aprile
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 547)
DOI
10.1200/jco.2015.33.3_suppl.547
Abstract #
547
Poster Bd #
A41
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Small bowel adenocarcinoma: A single center experience.
First Author: Lindsay Marie Hannan
Poster
2017 Gastrointestinal Cancers Symposium
Anti-KRAS siRNA nanoparticles for targeted colorectal cancer therapy.
First Author: Bradley Krasnick
Poster
2016 Gastrointestinal Cancers Symposium
Predictive value of ERCC1 and KRAS in colorectal cancer patients with FOLFOX chemotherapy.
First Author: In Kyu Lee
Poster
2015 ASCO Annual Meeting
ERCC1 induction after oxaliplatin exposure may depend on KRAS mutational status in colorectal cancer patient: preliminary data from liquid biopsy.
First Author: Mariantonietta Di Salvatore